(Q36350708)

English

In vivo administration of interleukin 2 plus T cell-depleted syngeneic marrow prevents graft-versus-host disease mortality and permits alloengraftment

scientific article

Statements

In vivo administration of interleukin 2 plus T cell-depleted syngeneic marrow prevents graft-versus-host disease mortality and permits alloengraftment (English)
1 March 1990
171
645-658

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit